CD8A and rheumatoid arthritis: Observational evidence indicated elevated levels of IL-2 in TMJ capsule fluid of TMDs patients (44) and an increased number of peripheral CD8+ CD25+ T cells in RA patients (45), suggesting a potential role for the IL-2 pathway in mediating RA-associated TMDs.